Top 5 Large Pharma selects PV Reports to support user, custom and ad-hoc reports, and regulatory Aggregate Reports

3 Aug 2022

A Top 5 pharma was striving to stay ahead of regulatory changes and ensure compliance around the globe. As a result, Top 5 pharma is revising its technology strategy within Adverse Event Management, reporting and analytics, with a strong focus on future-state, innovative architecture, and technology. The goal of becoming a world-class drug safety organization that is prepared to meet the long-term strategy.

Scope includes:

• PV Reports and PV Data Hub
• 2000+ global users
• On-premise global deployment
• Configure for self-service reporting
• Rework of report catalog inclusive of the following:
  • DSUR, PBRER, PADER
  • SAE case listing
  • Device line listing
  • All OOB reports

In addition, system users will be configuring custom reports within PV Reports.